Voyager Therapeutics (VYGR) Offers Interim Phase 1b Data on VY-AADC01 in PD Patients
Tweet Send to a Friend
Voyager Therapeutics, Inc. (Nasdaq: VYGR) reported interim surgical results from an ongoing Phase 1b study of VY-AADC01 in patients with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
